CompoAtlas

EQUILIBRE PHANERES

Food supplement declared in France, declaration No 2021-3-2160

EQUILIBRE PHANERES (Biophénix) is a food supplement declared in France. Status: retiré du marché le 13 May 2025. 1 rule of use applies to its ingredients (limits and warnings).

Brand
Biophénix
Food business operator placing the product on the market
GREEN TIME SA
Status
Retiré du marché le 13 May 2025
Form
Gélule
Daily dose
4 gélules par jour
Directions for use
Prendre 2 à 4 gélules par jour le matin
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Nourrissons (moins de 1 an), Sous anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Cheveux et ongles

Declaration 223671, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Oryza sativa L.GraineExtrait sec aqueux994 mg
Brassica oleracea L.Parties aériennesPoudre (de plantes séchées ou broyées)184 mg
Ribes nigrum L.FruitExtrait sec aqueux184 mg
Helianthus annuus L.GraineExtrait sec aqueux184 mg
Fucus vesiculosus L.ThalleExtrait sec aqueux110 mg

Additives

Hydroxypropyl Méthyl Cellulose

Other ingredients

Acacia senegal (L.) Willd.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Consultez votre médecin

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : Biophénix

Enter to analyse, Shift+Enter for a new line